Latest news with #KoninklijkePhilipsN.V.
Cision Canada
22-07-2025
- Business
- Cision Canada
Sotos Class Actions: Proposed Settlement Reached in National Class Actions Regarding Philips Respironics Devices Français
, July 21, 2025 /CNW/ - A proposed partial settlement has been reached concerning the Economic Loss Claims in the Canada-wide class actions, Morel v. Koninklijke Philips N.V. et al. and Roy v. Respironics Inc. et al. The class actions address claims from individuals, corporations, hospitals, or partnerships in Canada who purchased or used certain Philips Respironics CPAP, BiPAP, or ventilator devices that were part of a voluntary recall first announced on June 14, 2021. Key Partial Settlement Details: Settlement Fund: 20 million CAD to resolve Economic Loss Claims, covering money spent or lost as a result of replacing the device and participating in the voluntary recall. Compensation Plan: Class Members may be eligible to receive up to $125 per purchased device and a percentage (30%-90%) of the replacement cost if replacement costs were incurred and receipts can be provided, less legal and administration fees and disbursements. Number of potential affected members: More than 300,000. This partial settlement does not include personal injury claims. These claims are still ongoing, and Class Members in this settlement keep their right to continue with them. The courts in British Columbia and Quebec must approve the settlement for it to take effect. If approved, all class members who have not opted out of the class actions will be bound by its terms. Opting Out or Objecting Details regarding the approval of the settlement, including the process for allowing Class Members to opt out or object are available at the following address: Legal Fees Class Counsel will apply for the approval of fees amounting to a maximum of 30% of the total settlement and an honorarium for the British Columbia Representative Plaintiff, subject to court approval.
Business Insider
19-07-2025
- Business
- Business Insider
Jefferies Reaffirms Their Hold Rating on Koninklijke Philips N.V. (0LNG)
In a report released today, Julien Dormois from Jefferies maintained a Hold rating on Koninklijke Philips N.V., with a price target of €22.00. The company's shares closed yesterday at €21.20. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Dormois covers the Healthcare sector, focusing on stocks such as Siemens Healthineers AG, Koninklijke Philips N.V., and ConvaTec. According to TipRanks, Dormois has an average return of -6.0% and a 44.78% success rate on recommended stocks. In addition to Jefferies, Koninklijke Philips N.V. also received a Hold from TR | OpenAI – 4o's Lila Implantra in a report issued on July 16. However, on July 7, UBS maintained a Buy rating on Koninklijke Philips N.V. (LSE: 0LNG).
Business Upturn
15-05-2025
- Business
- Business Upturn
Automated External Defibrillators Market Size to Reach USD 2.20 Billion by 2030, Driven by Rising Prevalence of Cardiovascular Diseases Increases the Demand
US & Canada, May 15, 2025 (GLOBE NEWSWIRE) — According to a new comprehensive report from The Insight Partners, the global automated external defibrillators market is growing significantly with the increasing prevalence of cardiovascular diseases. The global Automated External Defibrillator (AED) market growth is driven by increasing awareness of sudden cardiac arrest, government mandates for AED installations in public spaces, and technological advancements enhancing device usability. Key players include Koninklijke Philips N.V., Stryker Corporation, ZOLL Medical Corporation, Nihon Kohden Corporation, and Mediana Co. Ltd., focusing on innovation and strategic partnerships to expand their global presence. To explore the valuable insights in the Automated External Defibrillators Market report, you can easily download a sample PDF of the report – Overview of Report Findings 1. Market Growth: The automated external defibrillators market is expected to reach a value of US$ 2.20 billion by 2030 from US$ 1.55 billion in 2023 at a CAGR of 4.5%. Growth in the automated external defibrillators market is mainly driven by the increased incidence of cardiovascular diseases (CVDs), which are responsible for more than one-third of all deaths across the world. Immediate defibrillation within a few minutes of cardiac arrest saves thousands of lives, leading to the growth in adoption of AEDs in public places as well as private spaces. Government campaigns and public access defibrillation (PAD) schemes have also picked up the pace of AED installation, assisted by legislation enforcing their presence at crowded locations. 2. Rising Cardiovascular Disease Incidence: The worldwide upsurge of cardiovascular diseases (CVDs) is the key driver fueling the rise of the automated external defibrillators (AED) market. CVDs such as heart attacks, arrhythmias, and sudden cardiac arrest (SCA) are the prime cause of fatality worldwide. As per estimates by the World Heart Federation, over half billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021. This expanding health burden has increased the necessity for timely, accessible, and effective emergency treatment such as AEDs. Sudden cardiac arrest, a life-threatening expression of CVD, may strike at any moment and needs to be treated immediately by defibrillation to re-establish normal heart rhythm. AEDs are created to be easy, portable, and accessible to non-medical staff, hence an essential instrument for first-responder treatment. With decreasing survival rates by about 10% per minute without defibrillation, the presence of AEDs can greatly enhance patient outcomes. With increasing CVD cases, the risk of SCA occurrences in public places, workplaces, and homes also increases. 3. Government Support and Public Access Programs: Many governments and health agencies are actively promoting the installation and use of AEDs through public access defibrillation (PAD) programs. These programs provide for greater accessibility of AEDs in areas of high public traffic and the education of laypersons in basic life support and device operation. Regulatory agencies also require AED installations in specific facilities, and in some jurisdictions, provide financial incentives or subsidies to promote compliance. In addition, legislative improvements to Good Samaritan laws are diminishing liability issues, encouraging people to act during emergencies. Combined, these drivers are not only growing the AED market but also making a more responsive and health-aware community, one where early action can significantly enhance cardiac arrest survival. 4. Geographical Insights: In 2023, North America led the market with a substantial revenue share, followed by Europe and APAC, respectively. Asia Pacific is expected to register the highest CAGR in the automated external defibrillators market during the forecast period. Get Sample PDF on The Latest Automated External Defibrillators Market Report: Market Segmentation By laser type, the automated external defibrillators market is segmented into alexandrite laser, diode laser, and Nd:YAG laser. The diode laser segment held the largest share in the automated external defibrillators market in 2022. Based on product type, the automated external defibrillators market is segmented into multiple standard wavelength and specific standard wavelength. The multiple standard wavelength segment held a larger share in the automated external defibrillators market in 2022. In terms of end user, the automated external defibrillators market is divided into beauty clinics, dermatology clinics, hospitals, and home use. The beauty clinics segment held the largest share in the automated external defibrillators market in 2022. The automated external defibrillators market is segmented into five major regions: North America, Europe, APAC, Middle East and Africa, and South and Central America. Competitive Strategy and Development Key Players: A few major companies operating in the automated external defibrillators market are Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Stryker, BPL Medical Technologies Pvt Ltd.; Schiller AG; Mediana Co., Ltd.; Nihon Koden Corp; Asahi Kasei Corp; ICU Medical Systems Inc; Progetti SRL; and Koninklijke Philips N.V. Trending Topics: Mobile and Digital Health Solutions, Home Healthcare, Cloud-Connected AED Management Systems, Wearable Cardioverter Defibrillators (WCDs), CPR Assist Devices, and Manual External Defibrillators Global Headlines on Automated External Defibrillators Market Avive Solutions Named #3 in Small and Mighty Category by Fast Company for the World's Most Innovative Companies Gujarat school installs Automated External Defibrillators Machine Purchase Premium Copy of Global Automated External Defibrillators Market Size and Growth Report (2025-2031) at: Conclusion The automated external defibrillators market is expected to witness significant growth with the rising global burden of cardiovascular diseases, growing public awareness, and increasing favorable government regulations. As sudden cardiac arrest continues to be a leading global cause of death, the necessity for rapid, convenient life-saving interventions has become a necessity. Developments in AED technology, such as connectivity, real-time monitoring, and intuitive interfaces, are rendering these devices more effective and convenient to employ. The report from The Insight Partners lists several stakeholders—including manufacturers, healthcare roviders, distributors and suppliers, and regulatory bodies—along with valuable insights to successfully navigate this evolving market landscape and unlock new opportunities. Talk to Us Directly: Trending Related Reports: About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit Mathur E-mail: [email protected] Phone: +1-646-491-9876 Press Release – Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Yahoo
15-05-2025
- Business
- Yahoo
Automated External Defibrillators Market Size to Reach USD 2.20 Billion by 2030, Driven by Rising Prevalence of Cardiovascular Diseases Increases the Demand
The automated external defibrillators market is segmented on the basis of type and end user. The report runs an in-depth analysis of market trends, key players, and future opportunities. US & Canada, May 15, 2025 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global automated external defibrillators market is growing significantly with the increasing prevalence of cardiovascular diseases. The global Automated External Defibrillator (AED) market growth is driven by increasing awareness of sudden cardiac arrest, government mandates for AED installations in public spaces, and technological advancements enhancing device usability. Key players include Koninklijke Philips N.V., Stryker Corporation, ZOLL Medical Corporation, Nihon Kohden Corporation, and Mediana Co. Ltd., focusing on innovation and strategic partnerships to expand their global explore the valuable insights in the Automated External Defibrillators Market report, you can easily download a sample PDF of the report - Overview of Report Findings 1. Market Growth: The automated external defibrillators market is expected to reach a value of US$ 2.20 billion by 2030 from US$ 1.55 billion in 2023 at a CAGR of 4.5%. Growth in the automated external defibrillators market is mainly driven by the increased incidence of cardiovascular diseases (CVDs), which are responsible for more than one-third of all deaths across the world. Immediate defibrillation within a few minutes of cardiac arrest saves thousands of lives, leading to the growth in adoption of AEDs in public places as well as private spaces. Government campaigns and public access defibrillation (PAD) schemes have also picked up the pace of AED installation, assisted by legislation enforcing their presence at crowded locations. 2. Rising Cardiovascular Disease Incidence: The worldwide upsurge of cardiovascular diseases (CVDs) is the key driver fueling the rise of the automated external defibrillators (AED) market. CVDs such as heart attacks, arrhythmias, and sudden cardiac arrest (SCA) are the prime cause of fatality worldwide. As per estimates by the World Heart Federation, over half billion people around the world continue to be affected by cardiovascular diseases, which accounted for 20.5 million deaths in 2021. This expanding health burden has increased the necessity for timely, accessible, and effective emergency treatment such as AEDs. Sudden cardiac arrest, a life-threatening expression of CVD, may strike at any moment and needs to be treated immediately by defibrillation to re-establish normal heart rhythm. AEDs are created to be easy, portable, and accessible to non-medical staff, hence an essential instrument for first-responder treatment. With decreasing survival rates by about 10% per minute without defibrillation, the presence of AEDs can greatly enhance patient outcomes. With increasing CVD cases, the risk of SCA occurrences in public places, workplaces, and homes also increases. 3. Government Support and Public Access Programs: Many governments and health agencies are actively promoting the installation and use of AEDs through public access defibrillation (PAD) programs. These programs provide for greater accessibility of AEDs in areas of high public traffic and the education of laypersons in basic life support and device operation. Regulatory agencies also require AED installations in specific facilities, and in some jurisdictions, provide financial incentives or subsidies to promote compliance. In addition, legislative improvements to Good Samaritan laws are diminishing liability issues, encouraging people to act during emergencies. Combined, these drivers are not only growing the AED market but also making a more responsive and health-aware community, one where early action can significantly enhance cardiac arrest survival. 4. Geographical Insights: In 2023, North America led the market with a substantial revenue share, followed by Europe and APAC, respectively. Asia Pacific is expected to register the highest CAGR in the automated external defibrillators market during the forecast period. Get Sample PDF on The Latest Automated External Defibrillators Market Report: Market Segmentation By laser type, the automated external defibrillators market is segmented into alexandrite laser, diode laser, and Nd:YAG laser. The diode laser segment held the largest share in the automated external defibrillators market in 2022. Based on product type, the automated external defibrillators market is segmented into multiple standard wavelength and specific standard wavelength. The multiple standard wavelength segment held a larger share in the automated external defibrillators market in 2022. In terms of end user, the automated external defibrillators market is divided into beauty clinics, dermatology clinics, hospitals, and home use. The beauty clinics segment held the largest share in the automated external defibrillators market in 2022. The automated external defibrillators market is segmented into five major regions: North America, Europe, APAC, Middle East and Africa, and South and Central America. Competitive Strategy and Development Key Players: A few major companies operating in the automated external defibrillators market are Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Stryker, BPL Medical Technologies Pvt Ltd.; Schiller AG; Mediana Co., Ltd.; Nihon Koden Corp; Asahi Kasei Corp; ICU Medical Systems Inc; Progetti SRL; and Koninklijke Philips N.V. Trending Topics: Mobile and Digital Health Solutions, Home Healthcare, Cloud-Connected AED Management Systems, Wearable Cardioverter Defibrillators (WCDs), CPR Assist Devices, and Manual External Defibrillators Global Headlines on Automated External Defibrillators Market Avive Solutions Named #3 in Small and Mighty Category by Fast Company for the World's Most Innovative Companies Gujarat school installs Automated External Defibrillators MachinePurchase Premium Copy of Global Automated External Defibrillators Market Size and Growth Report (2025-2031) at: Conclusion The automated external defibrillators market is expected to witness significant growth with the rising global burden of cardiovascular diseases, growing public awareness, and increasing favorable government regulations. As sudden cardiac arrest continues to be a leading global cause of death, the necessity for rapid, convenient life-saving interventions has become a necessity. Developments in AED technology, such as connectivity, real-time monitoring, and intuitive interfaces, are rendering these devices more effective and convenient to employ. The report from The Insight Partners lists several stakeholders—including manufacturers, healthcare roviders, distributors and suppliers, and regulatory bodies—along with valuable insights to successfully navigate this evolving market landscape and unlock new to Us Directly: Related Reports: Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit Mathur E-mail: Phone: +1-646-491-9876 Press Release - in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
29-03-2025
- Business
- Yahoo
Koninklijke Philips N.V. (PHG): Leading Medical Tech Patents with 1,231 Applications in 2024
We recently published a list of . In this article, we are going to take a look at where Koninklijke Philips N.V.'s (NYSE:PHG) stands against other top AI news updates investors probably missed. Artificial intelligence (AI) has been termed humanity's most significant invention in recent years. Others have argued that AI has the potential to enrich consumers' lives through new channels for self-expression and creativity. The best part is that this is not wishful thinking; big things are already happening. In fact, some believe the world is on the cusp of an AI technology that can reason and act at the same level as humans. According to Nathan Myhrvold, former Microsoft CTO and current CEO of Intellectual Ventures, humanity is less than five miracles away from creating AI with human-like cognitive abilities. 'We'll get there eventually… Two years ago, nobody would have predicted how far we've come today,' he said. But before AI can match or even surpass human intelligence, the technology is already showing great promise in various applications. For instance, one of Africa's wealthiest individuals is tapping the tech to build the continent's first AI factory. According to a Bloomberg report, Strive Masiyiwa's company will provide the infrastructure for African businesses, researchers, and startups to 'turn their bold ideas into real-world breakthroughs, and now they don't have to look beyond Africa to get it.' Across the Indian Ocean to Asia, AI is revolutionizing agriculture in China. Recent reports suggest that the government has initiated the development of an AI platform to support intelligent agricultural machines. Regional authorities have released a policy draft that outlines measures to encourage R&D in AI-based agricultural tools. This includes setting up innovation hubs to provide services like R&D, testing, exhibitions, and access to AI resources. The AI platform will assist companies in data verification, AI model implementation, and enhancing human-machine interaction. India, too, is keen on leveraging the AI wave. The country is working on an indigenous AI chip that should be ready in three years. This massive undertaking is under the purview of the Ministry of Electronics and Information Technology (MeitY). The objective is to reduce reliance on foreign semiconductor technology and strengthen India's position in the global AI ecosystem. Many other countries in North America and Europe have similar projects already underway or at the deliberation stage. The most exciting part of these developments is that the private sector is at the center of the revolution. Most, if not all, of these AI-focused projects may be government initiatives but it is the private sector that is doing the heavy lifting. To create this list, we reviewed the latest AI-focused news reports, press releases, and stock analysis. We have also mentioned the hedge fund sentiment around each stock, as of Q4 2024. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A medical professional using a magnetic resonance imaging (MRI) system to diagnose a patient in a hospital setting. Number of Hedge Fund Holders: 12 Koninklijke Philips N.V. (NYSE:PHG) is a global health technology company that works on meaningful innovation to improve people's lives. On March 25, the company confirmed it was the leading applicant of medical technology patents at the European Patent Office in 2024, with 1231 applications. The company continues to grow its patent portfolio, hoping to generate long-term value. The patent filing underscores Koninklijke Philips N.V.'s (NYSE:PHG) commitment to integrating informatics and artificial intelligence to improve workflows, enhance patient care and lower costs. The US Food and Drug Administration cleared some of its AI tools integrated into EPIQ CVx and Affiniti CVx ultrasound systems to enhance cardiovascular imaging. While the AI tools increase automation and productivity, they also strengthen Philips' position in the cardiovascular ultrasound segment. 'To continue driving greater impact, we have shifted our innovation closer to customers. We want to help healthcare professionals improve patient care and empower people everywhere to take care of their health and well-being,' Roy Jakobs, CEO of Royal Philips, said. Overall, PHG ranks 9th on our list of top AI news updates investors probably missed. While we acknowledge the potential of PHG as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than PHG but that trades at less than 5 times its earnings, check out our report about the . READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
